Literature DB >> 11532684

Cocaine use, hypertension, and end-stage renal disease.

K C Norris1, M Thornhill-Joynes, C Robinson, T Strickland, B L Alperson, S C Witana, H J Ward.   

Abstract

Cocaine use has been associated with both acute renal failure and hypertension (HTN), but only recently have data suggested it may lead to a chronic insidious form of renal failure. We designed a cross-sectional study to compare the association of cocaine use in hemodialysis patients with and without a diagnosis of HTN-related end-stage renal disease (HTN-ESRD). Two hundred one black patients from two outpatient hemodialysis units in an urban community were evaluated. There were 193 eligible patients, 106 men and 87 women, aged 49.28 +/- 14.4 years. A history of significant cocaine use before dialysis was reported by 55 of 193 subjects (28.5%). A diagnosis of HTN-ESRD was reported in 49 of 55 cocaine users (89.1%) compared with 64 of 138 nonusers (46.38%; odds ratio, 9.44; 95% confidence interval, 3.79 to 23.49; P < 0.0005). Of the 113 subjects with HTN-ESRD, 49 subjects (43.4%) had a history of cocaine abuse, either alone or in combination with other drugs. Subjects with HTN-ESRD with cocaine use were younger than those without cocaine use (40.7 +/- 9.0 versus 53.8 +/-15.3 years; P < 0.0005) and had a shorter reported duration of HTN (5.3 +/- 5.4 versus 12.7 +/- 9.8 years; P < 0.0005, adjusted for age and sex). In our urban dialysis population, a clinical diagnosis of HTN-ESRD was strongly associated with a history of cocaine use and earlier onset of ESRD. Cocaine should be considered as a cause of ESRD in patients without a clear cause of renal failure.

Entities:  

Mesh:

Year:  2001        PMID: 11532684     DOI: 10.1053/ajkd.2001.26845

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  18 in total

1.  Race and kidney disease: the scope of the problem.

Authors:  Keith C Norris; Lawrence Y Agodoa
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

Review 2.  [Sudden cardiac death. Selected forensic aspects].

Authors:  T Bajanowski; K Püschel; R Dettmeyer
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

3.  The role of race in survival among patients undergoing dialysis.

Authors:  Keith C Norris; Kamyar Kalantar-Zadeh; Joel D Kopple
Journal:  Nephrol News Issues       Date:  2011-12

4.  Nephropathology quiz page.

Authors:  Helen Liapis
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

5.  Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease.

Authors:  Joshua D Bundy; Lydia A Bazzano; Dawei Xie; Janet Cohan; Jacqueline Dolata; Jeffrey C Fink; Chi-Yuan Hsu; Kenneth Jamerson; James Lash; Gail Makos; Susan Steigerwalt; Xue Wang; Katherine T Mills; Jing Chen; Jiang He
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-07       Impact factor: 8.237

6.  Illicit drug use, hypertension, and chronic kidney disease in the US adult population.

Authors:  Sanjeev K Akkina; Ana C Ricardo; Amishi Patel; Arjun Das; Lydia A Bazzano; Carolyn Brecklin; Michael J Fischer; James P Lash
Journal:  Transl Res       Date:  2012-06-23       Impact factor: 7.012

7.  End-stage renal disease among HIV-infected adults in North America.

Authors:  Alison G Abraham; Keri N Althoff; Yuezhou Jing; Michelle M Estrella; Mari M Kitahata; C William Wester; Ronald J Bosch; Heidi Crane; Joseph Eron; M John Gill; Michael A Horberg; Amy C Justice; Marina Klein; Angel M Mayor; Richard D Moore; Frank J Palella; Chirag R Parikh; Michael J Silverberg; Elizabeth T Golub; Lisa P Jacobson; Sonia Napravnik; Gregory M Lucas
Journal:  Clin Infect Dis       Date:  2014-11-18       Impact factor: 9.079

Review 8.  Cerebrovascular and cardiovascular diseases caused by drugs of abuse.

Authors:  Yuichi Akasaki; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2019-12-05       Impact factor: 3.872

9.  Chromogranin A polymorphisms are associated with hypertensive renal disease.

Authors:  Rany M Salem; Peter E Cadman; Yuqing Chen; Fangwen Rao; Gen Wen; Bruce A Hamilton; Brinda K Rana; Douglas W Smith; Mats Stridsberg; Harry J Ward; Manjula Mahata; Sushi K Mahata; Donald W Bowden; Pamela J Hicks; Barry I Freedman; Nicholas J Schork; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

10.  Clinical Comorbidities among Cocaine Users Screened in the Community through HealthStreet.

Authors:  Sunita Dodani; Corrine W Ruktanonchai; Gurjit S Kaeley; Krishna Vaddiparti; Catherine W Striley; Linda B Cottler
Journal:  Health Behav Policy Rev       Date:  2016-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.